Stable gastric pentadecapeptide BPC 157-NO-system relation

P Sikiric, S Seiwerth, R Rucman… - Current …, 2014 - ingentaconnect.com
We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close
participation in Moncada's (maintained vascular integrity, platelets control) homeostatic …

Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157

P Sikiric, S Seiwerth, R Rucman… - Current …, 2013 - ingentaconnect.com
Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in
clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and …

[HTML][HTML] The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

CH Chang, WC Tsai, MS Lin… - Journal of applied …, 2011 - journals.physiology.org
Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body
protection compound (BPC) that is discovered in and isolated from human gastric juice …

Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

CH Chang, WC Tsai, YH Hsu, JH Su Pang - Molecules, 2014 - mdpi.com
BPC 157, a pentadecapeptide derived from human gastric juice, has been demonstrated to
promote the healing of different tissues, including skin, muscle, bone, ligament and tendon …

Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro

T Huang, K Zhang, L Sun, X Xue, C Zhang… - Drug design …, 2015 - Taylor & Francis
Chemical burns take up a high proportion of burns admissions and can penetrate deep into
tissues. Various reagents have been applied in the treatment of skin chemical burns; …

BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing

S Seiwerth, R Rucman, B Turkovic… - Current …, 2018 - ingentaconnect.com
Commonly, the angiogenic growth factors signify healing. However, gastrointestinal
ulceration is still poorly understood particularly with respect to a general pharmacological …

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

P Sikiric, S Seiwerth, R Rucman… - Current …, 2011 - ingentaconnect.com
Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in
inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, MW 1419, PL 14736) and …

BPC157 as potential agent rescuing from cancer cachexia

EA Kang, YM Han, JM An, YJ Park… - Current …, 2018 - ingentaconnect.com
Cancer cachexia, one of the metabolic syndromes caused by cancer, is a devastating and
miserable condition encountered in more than 50% of terminal cancer patients presenting …

[HTML][HTML] Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights

A Duzel, J Vlainic, M Antunovic… - World Journal of …, 2017 - ncbi.nlm.nih.gov
AIM To provide new insights in treatment of colitis and ischemia and reperfusion in rats
using stable gastric pentadecapeptide BPC 157. METHODS Medication [BPC 157, L-NAME …

Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator

P Sikiric, S Seiwerth, L Brcic, M Sever… - Current …, 2010 - ingentaconnect.com
The significance of cytoprotection and adaptive cytoprotection and the peptides importance
remained to be not completely determined. BPC 157 is an anti-ulcer peptidergic agent …